Error loading player: No playable sources found

Concurrent Session: Modern Modelling Using AI and Algorithm Based DOE - Benefits, Challenges and Validation

Date
November 2, 2021

Concurrent Session: This session discusses two topics in the landscape of modern modeling. In the first, attendees will be exposed to new categories of DoE options and learn the potential advantages of these modern designs compared to classical designs. The second topic focuses on the validation of AI applications. A validation strategy based on an AI maturity model is described, including the benefits of implementation of the maturity concept.

Leader/Speaker

Speaker Image for Tara Scherder
Principal, SynoloStats

Speakers

Speaker Image for Rolf Blumenthal
Business Developer, Körber Pharma Software
Speaker Image for Nico Erdmann
Senior Manager, Deloitte GmbH WPG

Related Products

Thumbnail for Concurrent Session: Ruling the Digital Transformation: Effective Data Management and Analytics in the Manufacturing Processes 
Concurrent Session: Ruling the Digital Transformation: Effective Data Management and Analytics in the Manufacturing Processes 
Concurrent Session: Ruling the Digital Transformation: Effective Data Management and Analytics in the Manufacturing Processes | Data really is the new oil, but how can we effectively rely on digital transformation as a business advantage? Applying efficient analytics methods unleash a complex amoun…
Thumbnail for AI as an Enabler for Automated Digital Cryo-EM Image Processing
AI as an Enabler for Automated Digital Cryo-EM Image Processing
In this talk, we provide insights from the GAMP D-A-CH local Special Interest Group AI case study conducted together with ATEM. In this case, cryo-electron microscopy images need to be assessed, regarding quality of loads in adeno-associated viruses (AAV)…
Thumbnail for AI Maturity Model for GxP Application - Setting the Foundation for the Validation of AI
AI Maturity Model for GxP Application - Setting the Foundation for the Validation of AI
Artificial Intelligence (AI) becomes increasingly important to the GxP-regulated areas of the pharmaceutical industry, while the validation of these systems remains uncertain…
Thumbnail for Updates on ICH Quality Topics: ICH Q12, Q14 and M4Q
Updates on ICH Quality Topics: ICH Q12, Q14 and M4Q
ICH delivers guidance on science- and risk-based strategies and is an enabler of greater harmonization worldwide to ensure that safe, effective, and high-quality medicines are developed and registered in the most resource-efficient manner…